![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
HA Singer and KM Baker
Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania.
Phorbol dibutyrate (PDB) is an activator of protein kinase C and has been observed to cause a slow developing contraction in vascular smooth muscle. The mechanism of phorbol ester-induced contraction is unknown. We studied the Ca++-dependence of, and the degree of myosin light chain phosphorylation (MLC-P), during PDB-induced contractions in rabbit aortic rings. PDB elicited concentration-dependent contractions (3 X 10(-8) to 10(-6) M) in rabbit aortic rings incubated in normal (1.6 mM Ca++) physiologic salt solution (PSS). Addition of the Ca++-channel blocker nifedipine (0.1 microM) to PSS or removal or Ca++ from PSS significantly reduced the contractile responses to PDB. Depletion of Ca++ by repeated washes in O Ca++-PSS containing 10(-3) M ethylene glycol bis(beta-aminoethyl ether)-N,N'-tetraacetic acid reduced, but did not eliminate, the responses to PDB. In PSS, PDB significantly increased the fraction of phosphorylated MLC/total MLC to 0.33 from a resting value of 0.20. Ca++ depletion reduced the resting fraction (MLC- P/MLC) to 0.14. PDB-stimulated contractions in Ca++-depleted tissues occurred in the absence of significant increases in MLC-P. Sodium nitroprusside partially relaxed PDB-induced contractions by approximately 50% whether elicited in the presence of 1.6 mM Ca++ or after Ca++ depletion. In both cases relaxation occurred in the absence of statistically significant decreases in MLC phosphorylation. Ca++- dependent MLC phosphorylation may account for a component of the PDB contractile response in rabbit aorta. Studies in the absence of Ca++ suggest that PDB may activate contraction without concomitant MLC-P.
This article has been cited by other articles:
|
|
 |
|
  C.-M. Hai and H. R. Kim An expanded latch-bridge model of protein kinase C-mediated smooth muscle contraction J Appl Physiol, April 1, 2005; 98(4): 1356 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Xiao, W. J. Pearce, L. D. Longo, and L. Zhang ERK-mediated uterine artery contraction: role of thick and thin filament regulatory pathways Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1615 - H1622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Xiao, X. Huang, S. Bae, C. A. Ducsay, L. D. Longo, and L. Zhang Cortisol-mediated regulation of uterine artery contractility: effect of chronic hypoxia Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H716 - H722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Civelek, K. Ainslie, J. S. Garanich, and J. M. Tarbell Smooth muscle cells contract in response to fluid flow via a Ca2+-independent signaling mechanism J Appl Physiol, December 1, 2002; 93(6): 1907 - 1917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lohn, D. Kampf, C. Gui-Xuan, H. Haller, F. C. Luft, and M. Gollasch Regulation of arterial tone by smooth muscle myosin type II Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1383 - C1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Menice, J. Hulvershorn, L. P. Adam, C.-L. A. Wang, and K. G. Morgan Calponin and Mitogen-activated Protein Kinase Signaling in Differentiated Vascular Smooth Muscle J. Biol. Chem., October 3, 1997; 272(40): 25157 - 25161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sasajima, H. Shima, Y. Toyoda, K. Kimura, A. Yoshikawa, T. Hano, and I. Nishio Increased Ca2+ sensitivity of contractile elements via protein kinase C in {alpha}-toxin permeabilized SMA from young spontaneously hypertensive rats Cardiovasc Res, October 1, 1997; 36(1): 86 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. D. Sohn, D. Zoukhri, D. Dartt, C. Sergheraert, K. M. Harnett, J. Behar, and P. Biancani Different Protein Kinase C Isozymes Mediate Lower Esophageal Sphincter Tone and Phasic Contraction of Esophageal Circular Smooth Muscle Mol. Pharmacol., March 1, 1997; 51(3): 462 - 470. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
